Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
Running, not enrolling · Phase 3
Conditions studied: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
In brief
This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab versus docetaxel (standard of care) in participants with locally advanced (unresectable stage IIIB/C) or programmed death ligand 1 (PD-L1)-positive metastatic non-small cell lung cancer (NSCLC) who have been treated with programmed cell death protein 1 (PD-1)/PD-L1 inhibitor and platinum-containing chemotherapy, administered either in combination or sequentially in the locally advanced (unresectable stage IIIB/C) or metastatic setting.
Key facts
- Study ID
- NCT06635824
- Run by
- Genmab
- People needed
- 191
- Starts
- 2024-11-25
- Expected to finish
- 2028-09-30
- Last updated by the study team
- 2026-08-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Usc Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Kaiser Permanente Vallejo Medical Center — Vallejo, California, United States
- Ocala Oncology Center P.L. — Ocala, Florida, United States
- Orlando Regional Medical Center — Orlando, Florida, United States
- University Cancer & Blood Center, LLC — Athens, Georgia, United States
- Piedmont Cancer Institute Atlanta — Atlanta, Georgia, United States
- Piedmont Cancer Institute - Sandy Springs (Atlanta) Office — Atlanta, Georgia, United States
- Piedmont Cancer Institute - Fayetteville Office — Fayetteville, Georgia, United States
- Piedmont Cancer Institute - Newnan Office — Newnan, Georgia, United States
- Piedmont Cancer Institute - Stockbridge Office — Stockbridge, Georgia, United States
- Kaiser Foundation Hospitals — Honolulu, Hawaii, United States
- University of Illinois — Chicago, Illinois, United States
- Community Cancer Center East Medical Oncology Hematology — Indianapolis, Indiana, United States
- Baptist Health Lexington — Lexington, Kentucky, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Pikeville Medical Center — Pikeville, Kentucky, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- St. Francis Hospital - Grand Island — Grand Island, Nebraska, United States
- Oncology Hematology West — Omaha, Nebraska, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists — Omaha, Nebraska, United States
- Stony Brook University Medical Center|University Medical Center — Stony Brook, New York, United States
- Novant Health Pharmacy — Charlotte, North Carolina, United States
- Novant Health Oncology Specialists — Winston-Salem, North Carolina, United States
- University of Pennsylvania Health System — Philadelphia, Pennsylvania, United States
- Arizona Blood and Cancer Specialists — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.